摘要
对公司连续制备的3批次猪肺炎支原体灭活疫苗进行了实验室检验(安全性、效力性)和初步临床应用(安全性、效力性)。结果表明该产品对免疫猪安全,并且可使免疫猪肺炎病变减少率达到80%以上,临床应用免疫效果明显。
In this study, we checked 3 lasting batches of swine Mycoplasma hyopneumoniae inactivated vaccines in the laboratory （ security and effective ） , and the immune effect was verified by preliminary clinical application. The results showed that the vaccine was safe to swine, and the immune protective rate was over 80%. Totally the clinical immune effect was obvious.
出处
《中国动物保健》
2016年第12期87-88,共2页
China Animal Health
基金
保定市科技计划项目(16J01)
关键词
猪肺炎支原体
实验室检验
临床应用
Mycoplasma hyopneumoniae
Laboratory test
Clinical application
